Eton Pharmaceutcials, Inc. Common Stock vs. Eli Lilly & Co.
Eli Lilly & Co. (LLY) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| ETON | LLY | |
|---|---|---|
| Market Cap | $1.68 billion | $1.05 trillion |
| Revenue (TTM) | $105.59 million | $79.67 billion |
| Net Income (TTM) | $12.69 million | $26.71 billion |
LLY leads on 3 of 3 size & scale factors.
Valuation
| ETON | LLY | |
|---|---|---|
| P/E Ratio | — | 39.72 |
| Price / Book | 36.11 | 31.05 |
| Price / Sales | 15.93 | 13.20 |
LLY leads on 2 of 2 valuation factors.
Profitability
| ETON | LLY | |
|---|---|---|
| Net Margin | 12.02% | 33.53% |
| Return on Equity | 27.24% | 78.84% |
LLY leads on 2 of 2 profitability factors.
Dividend
| ETON | LLY | |
|---|---|---|
| Dividend Yield | — | 0.58% |
| Payout Ratio | — | 23.23 |
ETON and LLY split the dividend factors evenly.
Risk & Sentiment
| ETON | LLY | |
|---|---|---|
| Short Interest | 0.21% | 1.29% |
ETON leads on 1 of 1 risk & sentiment factors.
Dig deeper: ETON overview, ETON financials, LLY overview, LLY financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
